| Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis D Adams, A Gonzalez-Duarte, WD O’Riordan, CC Yang, M Ueda, ... New england journal of medicine 379 (1), 11-21, 2018 | 2382 | 2018 |
| Humanized anti-interleukin-6 receptor antibody suppresses tumor angiogenesis and in vivo growth of human oral squamous cell carcinoma S Shinriki, H Jono, K Ota, M Ueda, M Kudo, T Ota, Y Oike, M Endo, ... Clinical Cancer Research 15 (17), 5426-5434, 2009 | 211 | 2009 |
| Long-term survival after liver transplantation in patients with familial amyloid polyneuropathy T Yamashita, Y Ando, S Okamoto, Y Misumi, T Hirahara, M Ueda, ... Neurology 78 (9), 637-643, 2012 | 184 | 2012 |
| Recent advances in transthyretin amyloidosis therapy M Ueda, Y Ando Translational neurodegeneration 3, 1-10, 2014 | 151 | 2014 |
| Clinicopathological features of senile systemic amyloidosis: an ante-and post-mortem study M Ueda, Y Horibata, M Shono, Y Misumi, T Oshima, Y Su, M Tasaki, ... Modern Pathology 24 (12), 1533-1544, 2011 | 151 | 2011 |
| Amyloid deposits derived from transthyretin in the ligamentum flavum as related to lumbar spinal canal stenosis A Yanagisawa, M Ueda, T Sueyoshi, T Okada, T Fujimoto, Y Ogi, ... Modern pathology 28 (2), 201-207, 2015 | 143 | 2015 |
| Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm Y Sekijima, M Ueda, H Koike, S Misawa, T Ishii, Y Ando Orphanet journal of rare diseases 13, 1-17, 2018 | 140 | 2018 |
| Wild-type transthyretin-derived amyloidosis in various ligaments and tendons T Sueyoshi, M Ueda, H Jono, H Irie, A Sei, J Ide, Y Ando, H Mizuta Human pathology 42 (9), 1259-1264, 2011 | 137 | 2011 |
| Early diagnosis of ATTR amyloidosis through targeted follow-up of identified carriers of TTR gene mutations I Conceição, T Damy, M Romero, L Galán, S Attarian, M Luigetti, M Sadeh, ... Amyloid 26 (1), 3-9, 2019 | 127 | 2019 |
| Amyloid fibrils containing fragmented ATTR may be the standard fibril composition in ATTR amyloidosis E Ihse, C Rapezzi, G Merlini, MD Benson, Y Ando, OB Suhr, S Ikeda, ... Amyloid 20 (3), 142-150, 2013 | 125 | 2013 |
| JCS 2020 guideline on diagnosis and treatment of cardiac amyloidosis H Kitaoka, C Izumi, Y Izumiya, T Inomata, M Ueda, T Kubo, J Koyama, ... Circulation Journal 84 (9), 1610-1671, 2020 | 123 | 2020 |
| Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study D Adams, M Polydefkis, A González-Duarte, J Wixner, AV Kristen, ... The Lancet Neurology 20 (1), 49-59, 2021 | 116 | 2021 |
| A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation Y Ando, H Terazaki, M Nakamura, E Ando, K Haraoka, T Yamashita, ... Transplantation 77 (3), 345-349, 2004 | 113 | 2004 |
| Distinct characteristics of amyloid deposits in early-and late-onset transthyretin Val30Met familial amyloid polyneuropathy H Koike, Y Ando, M Ueda, Y Kawagashira, M Iijima, J Fujitake, M Hayashi, ... Journal of the neurological sciences 287 (1-2), 178-184, 2009 | 107 | 2009 |
| Interleukin‐6 signalling regulates vascular endothelial growth factor‐C synthesis and lymphangiogenesis in human oral squamous cell carcinoma S Shinriki, H Jono, M Ueda, K Ota, T Ota, T Sueyoshi, Y Oike, M Ibusuki, ... The Journal of pathology 225 (1), 142-150, 2011 | 93 | 2011 |
| Identification of CXCL5/ENA‐78 as a factor involved in the interaction between cholangiocarcinoma cells and cancer‐associated fibroblasts H Okabe, T Beppu, M Ueda, H Hayashi, T Ishiko, T Masuda, R Otao, ... International journal of cancer 131 (10), 2234-2241, 2012 | 92 | 2012 |
| Iatrogenic amyloid neuropathy in a Japanese patient after sequential liver transplantation T Goto, T Yamashita, M Ueda, S Ohshima, K Yoneyama, M Nakamura, ... American journal of transplantation 6 (10), 2512-2515, 2006 | 89 | 2006 |
| Midkine in plasma as a novel breast cancer marker M Ibusuki, H Fujimori, Y Yamamoto, K Ota, M Ueda, S Shinriki, ... Cancer science 100 (9), 1735-1739, 2009 | 83 | 2009 |
| Shikonin, dually functions as a proteasome inhibitor and a necroptosis inducer in multiple myeloma cells N Wada, Y Kawano, S Fujiwara, Y Kikukawa, Y Okuno, M Tasaki, M Ueda, ... International journal of oncology 46 (3), 963-972, 2015 | 80 | 2015 |
| SELDI-TOF mass spectrometry evaluation of variant transthyretins for diagnosis and pathogenesis of familial amyloidotic polyneuropathy M Ueda, Y Misumi, M Mizuguchi, M Nakamura, T Yamashita, Y Sekijima, ... Clinical chemistry 55 (6), 1223-1227, 2009 | 77 | 2009 |
